<DOC>
	<DOCNO>NCT01030939</DOCNO>
	<brief_summary>The purpose study determine whether SB-649868 safe , tolerable repeat administration adult elderly healthy volunteer . Pharmacokinetics effect cardiac function repeat dos study</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability , Pharmacokinetics Cardiac Function After Repeat Doses SB-649868 Healthy-volunteers</brief_title>
	<detailed_description>The present clinical study ass safety , tolerability pharmacokinetics SB-649868 20mg administer 28 consecutive day adult ( 18 65 yr old ) elderly ( &gt; 65 yrs old ) men woman . The study also assess cardiac function use echocardiography .</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>1 . Healthy male female subject determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure . However , Subjects cTpn I value 99th percentile normal range select assay always exclude enrollment ; Subjects AST ALT &gt; 2xULN always exclude enrollment ; Subjects alkaline phosphatase bilirubin &gt; 1.5xULN always exclude ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . 2 . Age &gt; equal 18 year ( apply Cohort 1 2 ) ; age &gt; 65 year ( apply Cohort 3 4 ) ; 3 . Body weight ≥50 kg BMI within range 18.529.9 kg/m2 inclusive . Slight deviation value discuss approve Investigator GSK Medical Monitor allow subject inclusion study 4 . Male subject must agree use one contraception method list Section 8.1 . This criterion must follow time first dose study medication 3 day post last dose ( equivalent 5 terminal halflives postlast dose ) . 5 . A female subject eligible participate : Nonchildbearing potential define premenopausal female document tubal ligation hysterectomy ; postmenopausal define 12 month spontaneous amenorrhea [ questionable case blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 MlU/mL estradiol &lt; 40 pg/ml ( &lt; 140 pmol/L ) confirmatory ] . Females hormone replacement therapy ( HRT ) whose menopausal status doubt require use one contraception method Section 8.1 wish continue Hormone Replacement Therapy ( HRT ) study . Otherwise , must discontinue HRT allow confirmation postmenopausal status prior study enrollment . For form HRT , least 24 week elapse cessation therapy blood draw ; interval depend type dosage HRT . Following confirmation postmenopausal status , resume use HRT study without use contraceptive method Childbearing potential agrees use one contraception method list Section 8.1 appropriate period time ( determined product label investigator ) prior start dose sufficiently minimize risk pregnancy point . Female subject must agree use contraception 6 week follow discontinuation study medication . 6 . Having give write informed consent , include compliance requirement restriction list consent form . 7 . Average QTcB QTcF &lt; 450 msec ; PQ 120220ms ; QRS &lt; 120ms ; significant rhythm disorder SCR 24h HolterECG 1 . History presence significant psychiatric , neurological , respiratory , gastrointestinal , hepatic , pancreatic renal disease condition know interfere absorption , distribution , metabolism excretion drug . 2 . History cardiovascular disease and/or evidence repolarization defect 3 . History regular alcohol consumption within 6 month study define : • average weekly intake great 21 unit ( 14 unit female ) average daily intake great 3 unit ( 2 unit female ) . 1 unit equivalent halfpint ( 220mL ) beer 1 ( 25ml ) measure spirit 1 glass ( 125ml ) wine . 4 . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . 5 . Vulnerable subject , subject mentally legally incapacitate , language barrier preclude adequate understanding cooperation . 6 . Any history suicidal behaviour suicidal ideation type 4 5 last month CSSRS administer screen 7 . Pregnant female determine positive Serum betahCG test screen prior dosing . 8 . Lactating female . 9 . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen 10 . A positive test HIV antibody . 11. cTpn I value 99th percentile laboratory reference interval 12 . A positive prestudy drug/alcohol screen . 13 . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . 14 . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . 15 . Consumption broccoli , radish sprout , cauliflower , cabbage , orange juice , grapefruit juice grapefruit within 7 day prior first dose study medication collection final pharmacokinetic blood sample . 16 . The subject participate clinical trial receive IP within follow time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect IP ( whichever longer ) . 17 . Exposure four new chemical entity within 12 month prior first dose day . 18 . Where participation study would result donation blood blood product excess 500 mL within 56 day period . 19 . Unwillingness inability follow procedure outline protocol . 20 . The subject unable unwilling abstain strenuous physical activity 48 h screen follow visit . 21 . Subject investigator his/her deputy , research assistant , pharmacist , study coordinator , staff relative thereof involve conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Men woman</keyword>
	<keyword>adult elderly</keyword>
	<keyword>repeat dose</keyword>
</DOC>